Health
Improve our lives while reducing societal costs
Health is at the heart of our daily concerns and achieving a good quality of life for everyone, with a controlled societal cost, is a major challenge for the coming decades across the world. Living older must be accompanied by a requirement for increased quality of life, from a health point of view, but solutions can only be implemented if they are economically acceptable for society.
What are the biggest challenges in this sector for the next decade ?
Among the many challenges facing the health sector, several challenges seem particularly important to us for the coming decades:
- The fight against cancer, which causes 1 in 6 deaths worldwide and is the leading cause of death. The aging of the population should reinforce this phenomenon.
- The fight against silent diseases, but whose impact is real on the quality of life or life expectancy of patients (type II diabetes)
- The preservation of mental health, which affects 25% of the European population, with real impacts on the quality of life and the ability of patients to participate fully in the country’s activity
- Reducing healthcare costs, thanks to innovative solutions allowing for better care (e.g. chronic wounds)
Why we believe deeptech can solve the biggest challenges ?
Major innovations in the field of health almost all come from academic research, so it is natural to try to optimize the transfer rate between this research work and applications in human health. The development of multi-disciplinary teams (chemistry, biology, physics) and collaborations between these teams and clinicians makes it possible to significantly increase the number and quality of technological assets developed within European academic laboratories.
What kind of project do we want to create there ?
We are looking for projects with the potential to have a very broad environmental, societal and economic impact. Here are some examples of topics that caught our attention:
- Development of therapeutic solutions to treat cancers resistant to current therapies
- Medical devices to improve the quality of life of patients drastically at low cost or by reducing costs for society
- Mass diagnostic technologies to detect the most common pathologies earlier but have a strong impact on the life expectancy of patients in the event of late detection